Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.

Ute EisenbergerKlemens BuddeFrank LehnerClaudia SommererPetra ReinkeOliver WitzkeRudolf P WüthrichRolf StahlKatharina HellerBarbara SuwelackAnja MühlfeldIngeborg A HauserSilvio NadalinMartina PorstnerWolfgang Arnsnull null

Published in: BMC nephrology (2018)

ClinicalTrials.gov NCT00154310 . Date of registration: September 12, 2005.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
double blind
open label
clinical trial
patient reported outcomes
phase iii